Zoster Vaccination Pearls

Rx Shorts: With 2 shingles vaccines available, questions continue to multiply. Take away 4 small pearls to help answer patient questions and yours.
Source: ConsultantLive - Category: Internal Medicine Authors: Tags: Immunization Infectious Disease Vaccines Source Type: news

Related Links:

Shingles is becoming less common in both adults and children in the U.S., according to results from a database study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
(MedPage Today) -- Vaccine development may help with prevention of herpes zoster in this population
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
This report evaluates the fifth year of the shingles vaccination programme in England from 2017 to 2018.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
hon Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia. Decades later, the virus may reactivate either spontaneously or after a number of triggering factors to cause herpes zoster (shingles). Varicella and its complications are more severe in the immunosuppressed. The most frequent and important complication of VZV reactivation is postherpetic neuralgia, the cause of which is unknown and for which treatment is usually ineffective. Reactivation of VZV may also cause a wide variety of neurologic...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
AbstractThe herpes zoster (shingles) vaccine is recommended for all adults aged ≥ 60 years without contraindications to prevent shingles and post-herpetic neuralgia. There are no published studies on zoster vaccination rates, barriers, or workflows in adults who have experienced homelessness. Due to barriers specific to this vaccine, including difficulty determining insura nce coverage, high upfront costs, need for storage in a freezer, and under-prescription by physicians, uptake is lower compared to other recommended vaccines for older adults. To address these barriers, we developed a new approach of partn...
Source: Journal of Community Health - Category: International Medicine & Public Health Source Type: research
Gelatine is added as a stabiliser to prevent vaccines degrading in transportation. In the UK, the worst offenders are the nasal flu vaccine Fluenz Tetra, the shingles jab Zostavax and the MMR.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The newer shingles vaccine Shingrix was far more successful in preventing the condition compared with the older vaccine Zostavax among patients 50 and older.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
(St. Michael's Hospital) A systematic review of clinical studies involving more than two million patients aged 50 years and older suggests the newer shingles vaccine Shingrix was far more successful in preventing the painful condition compared to the older vaccine Zostavax.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(Natural News) In the 1980s, after a series of very serious lawsuits against vaccine companies from healthcare providers due to vaccine injuries, the CDC, in cahoots with vaccine manufacturers, created the Vaccine Injury Compensation Program (VICP) so that no vaccine maker could ever be sued again. From that date forward, if any U.S. person was...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
PMID: 30277735 [PubMed - in process]
Source: American Family Physician - Category: Primary Care Authors: Tags: Am Fam Physician Source Type: research
More News: Infectious Diseases | Internal Medicine | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine